Characterization of variables for potential impact on vancomycin pharmacokinetics in thermal or inhalation injury
Burns Nov 08, 2017
Elder K, et al. - This study is planned to assess the pharmacokinetics of vancomycin dosing in thermal or inhalation injury as they relate to percent total body surface area burn (TBSA) and days since injury (DSI). Authors suggest that DSI, percent TBSA, and Creatinine clearance (CrCl) may be predictive of faster vancomycin CL and need for higher total daily doses. Findings suggest the occurrence of augmented pharmacokinetics as early as two days after an injury that decreases with time. Acceptable target trough attainment is still lacking. Therefore, for initial vancomycin dosing, this data should assist in performance improvements.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries